Generate Biomedicines, Inc.(GENB)

Biotechnology · Somerville, MA

$13.90-0.01 (-0.04%)

Delayed quote: Oct 6, 2026, 2:00 PM EDT

Compare

All Metrics

Dividend status: Never paid. No positive dividend payment is present in the available history.

GENB Valuation Metrics

PE RatioN/A PE Ratio (Fwd)N/A PS RatioN/A PB Ratio3.91 PFCF Ratio

Last Updated: Tuesday, October 6, 2026

About Generate Biomedicines, Inc.

Generate Biomedicines, Inc. is a U.S.-based company pioneering generative biology, leveraging machine learning for the discovery and advancement of novel protein therapeutics. Their core approach involves developing drugs using protein-based modalities. The company's pipeline includes several key candidates: GB-0895, an investigational long-acting anti-TSLP monoclonal antibody designed for bi-annual dosing in severe asthma; GB-4362, an MMAE payload neutralizer monoclonal antibody; and GB-5267, a MUC16 CAR-T cell therapy. Integral to their work is the Generate Platform, a sophisticated system engineered to be versatile across diverse therapeutic areas and protein modalities. This platform combines computational innovation with scalable biohardware, allowing them to tackle therapeutic hurdles beyond the capabilities of traditional technologies. Established in 2018, the company was initially known as Generate Biologics, Inc. before rebranding to Generate Biomedicines, Inc. in February 2020. Its headquarters are located in Somerville, Massachusetts.

Somerville, MA

312 employees

generatebiomedicines.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Michael T. Nally

View full financials

7D Total Return	-6.71%
30D Total Return	-15.13%
YTD Total Return	N/A
1Y Total Return	N/A
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

Debt/Equity Ratio	0.14
Debt/Equity Ratio Avg TTM	0.05
Debt/Equity Ratio Avg 3Y	0.05
Current VS TTM Avg	+168.48%
Current VS 3Y Avg	+168.48%
Current VS 5Y Avg	+168.48%

Current Ratio	8.30
Current Ratio Avg TTM	6.77
Current Ratio Avg 3Y	6.77
Current VS TTM Avg	+22.56%
Current VS 3Y Avg	+22.56%
Current VS 5Y Avg	+22.56%

Quick Ratio	8.30
Quick Ratio Avg TTM	6.77
Quick Ratio Avg 3Y	6.77
Current VS TTM Avg	+22.56%
Current VS 3Y Avg	+22.56%
Current VS 5Y Avg	+22.56%

ROIC	(94.79%)
ROIC Avg 3Y	(70.21%)
ROIC Avg 5Y	(70.21%)
Current VS 3Y Avg	-35.01%
Current VS 5Y Avg	-35.01%
Current VS 10Y Avg	-35.01%

All Metrics

GENB Valuation Metrics

All Metrics

GENB Valuation Metrics

GENB Stock Price Metrics

GENB Dividend Metrics

GENB Growth Rate Metrics

GENB Discounted Cash Flow Metrics

GENB Returns By Period

GENB Yearly Returns

GENB Average Annual Returns By Period (CAGR)

GENB Revenue Metrics

GENB PE Ratio Metrics

GENB PS Ratio Metrics

GENB PB Ratio Metrics

GENB Price to Free Cash Flow Ratio Metrics

GENB Debt to Equity Ratio Metrics

GENB PEG Ratio Metrics

GENB FCF Yield

GENB Earnings Yield

GENB EBITDA Yield

GENB OCF Yield

GENB EV/EBIT Ratio Metrics

GENB EV/EBITDA Ratio Metrics

GENB EV/Assets Ratio Metrics

GENB EV/Sales Ratio Metrics

GENB Current Ratio Metrics

GENB Quick Ratio Metrics

GENB ROIC Metrics

GENB Return on Assets Metrics

GENB Return on Equity Metrics

GENB Net Profit Margin Metrics

GENB Gross Profit Margin Metrics

GENB Tax Rate Metrics

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

CAGR TTM	N/A
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	N/A
PB Ratio Avg TTM	N/A
PB Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	N/A
Ev/Assets Ratio Avg TTM	N/A
Ev/Assets Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

ROA	(61.53%)
ROA Avg TTM	(7.26%)
ROA Avg 3Y	(7.26%)
Current VS TTM Avg	-747.00%
Current VS 3Y Avg	-747.00%
Current VS 5Y Avg	-747.00%

ROE	N/A
ROE Avg TTM	36.48%
ROE Avg 3Y	36.48%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Net Profit Margin	(636.99%)
Net Profit Margin Avg TTM	(638.58%)
Net Profit Margin Avg 3Y	(638.58%)
Current VS TTM Avg	+0.25%
Current VS 3Y Avg	+0.25%
Current VS 5Y Avg	+0.25%

Gross Profit Margin	100.00%
Gross Pft Margin Avg TTM	51.56%
Gross Pft Margin Avg 3Y	51.56%
Current VS TTM Avg	+93.93%
Current VS 3Y Avg	+93.93%
Current VS 5Y Avg	+93.93%

Tax Rate	(0.07%)
Tax Rate Avg 3Y	(0.10%)
Tax Rate Avg 5Y	(0.10%)
Current VS 3Y Avg	+26.32%
Current VS 5Y Avg	+26.32%
Current VS 10Y Avg	+26.32%